Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4064515 | 0.87 | KDM4E (0.34) | TSHRSMN1; SMN2CYP2D6CYP3A4 | |
| SCHEMBL4069612 | 0.79 | S1PR1 (0.43) | CYP2D6CYP1A2DRD2DRD3ALDH1A1 | |
| SCHEMBL4065507 | 0.78 | TSHR (0.39) | TSHRCYP2D6CYP3A4USP2CYP1A2 | |
| SCHEMBL24508756 | 0.75 | CYP2D6 (0.49) | TSHRCYP2D6CYP3A4USP2CYP1A2 | |
| SCHEMBL21107120 | 0.74 | TSHR (0.41) | TSHRDRD2DRD3 | |
| SCHEMBL4069282 | 0.74 | CYP3A4 (0.32) | TSHRSMN1; SMN2CYP2D6CYP3A4USP2 | |
| SCHEMBL4070868 | 0.74 | CYP3A4 (0.38) | TSHRCYP2D6CYP3A4USP2CYP1A2 | |
| SCHEMBL24746614 | 0.73 | OPRM1 (0.42) | TSHRCYP2D6CYP3A4USP2CYP1A2 | |
| SCHEMBL4065590 | 0.73 | HSD11B1 (0.40) | TSHRCYP2D6CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL24073328 | 0.73 | TSHR (0.36) | TSHRDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2032535-B1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | SANOFI SA (FR) | 2012-08-01 | — | — | EP | claimed |
| EP-2032535-A1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | Sanofi-Aventis (FR) | 2009-03-11 | — | — | EP | claimed |
| WO-2007137738-A1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | SANOFI-AVENTIS (DE) | 2007-12-06 | — | — | WO | claimed |
| EP-2520568-A1 | Spirocyclic nitriles as inhibitors of protease | SANOFI (FR) | 2012-11-07 | — | — | EP | disclosed |
| EP-2032535-B1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | SANOFI SA (FR) | 2012-08-01 | — | — | EP | disclosed |
| EP-2032535-A1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | Sanofi-Aventis (FR) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007137738-A1 | SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS | SANOFI-AVENTIS (DE) | 2007-12-06 | — | — | WO | disclosed |